9/14/2026
Psyence BioMed forms Texas entity for U.S. ibogaine research
Texas Ibogaine Research Corporation to spearhead U.S. ibogaine development efforts.
Topic archive
u.s. department of health and human services
6 stories
9/10/2026
Rhelion Life Sciences launches stability program for ibogaine
Filament Health begins stability testing for IBEX011, a botanical ibogaine drug.
9/10/2026
Rhelion Life Sciences launches ibogaine stability program
Filament Health begins stability program for IBEX011 amid rising ibogaine demand.
9/10/2026
Filament Health plans stability program for ibogaine drug
IBEX011 stability program aims to meet growing demand for standardized ibogaine.
8/26/2026
University of Miami gifts 1994 ibogaine IND to HHS
The move promotes open science and could influence future psychedelic research.
7/15/2026
HHS and VA collaborate to advance psychedelic therapy
New agreement includes ibogaine research for opioid use disorder.